rs560471003
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_000310.4(PPT1):c.535C>T(p.Arg179Cys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000188 in 1,612,420 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000310.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPT1 | NM_000310.4 | c.535C>T | p.Arg179Cys | missense_variant, splice_region_variant | 5/9 | ENST00000642050.2 | NP_000301.1 | |
PPT1 | NM_001363695.2 | c.535C>T | p.Arg179Cys | missense_variant, splice_region_variant | 5/8 | NP_001350624.1 | ||
PPT1 | NM_001142604.2 | c.226C>T | p.Arg76Cys | missense_variant, splice_region_variant | 2/6 | NP_001136076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPT1 | ENST00000642050.2 | c.535C>T | p.Arg179Cys | missense_variant, splice_region_variant | 5/9 | NM_000310.4 | ENSP00000493153 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151884Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000350 AC: 88AN: 251414Hom.: 1 AF XY: 0.000434 AC XY: 59AN XY: 135882
GnomAD4 exome AF: 0.000198 AC: 289AN: 1460420Hom.: 4 Cov.: 32 AF XY: 0.000275 AC XY: 200AN XY: 726628
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152000Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74256
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis 1 Uncertain:1Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 30, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 14, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2020 | The p.R179C variant (also known as c.535C>T), located in coding exon 5 of the PPT1 gene, results from a C to T substitution at nucleotide position 535. The arginine at codon 179 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at